Riskpilot← Back to searchSign inGet full accessReceptor Holding ApS
APSActiveCVR 39115476Vodroffsvej 2B, 1. tvActivities of holding companies · NACE 6421Est. 2017— employees
Revenue 2024
DKK -39K
+158% vs 2023
EBITDA margin
100.0%
-157% vs 2023
Equity ratio
97.2%
Financial strength
Net profit 2024
DKK 1,6M
-91% vs 2023
| Revenue | DKK -39K | +158% |
| EBITDA | DKK -39K | -157% |
| Net profit | DKK 1,6M | -91% |
| Total assets | DKK 18,7M | -8% |
| Equity | DKK 18,2M | -10% |
| Employees | — | — |
Legal name
Receptor Holding ApS
CVR number
39115476
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
16. november 2017
Share capital
DKK 45.000
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af hele direktionen i forening eller af en direktør alene.
Company purpose
Selskabets formål er at foretage investeringer i aktiver, herunder immaterielle, og aktiviteter relaterede til forskning og udvikling rettet mod fremstilling og kommercialisering af lægemidler, medicinsk udstyr og/eller kosttilskud, og andre hermed relaterede aktiviteter.
Address
Vodroffsvej 2B, 1. tv
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | -10 | -52 | -38 | 0 | -12 | -15 | -39 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -10 | -52 | -38 | -15 | -12 | -15 | -39 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -10 | -52 | -38 | -15 | -12 | -15 | -39 |
| Net financials | 279 | 1.616 | 3.250 | -133 | 133 | 17.291 | 2.091 |
| Profit before tax | 269 | 1.564 | 3.211 | -148 | 121 | 17.276 | 2.052 |
| Tax | -0 | -0 | -0 | -0 | -0 | 2 | 452 |
| Net profit | 269 | 1.564 | 3.211 | -148 | 121 | 17.274 | 1.600 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 335 | 52 | 3.271 | 3.123 | 3.093 | 20.260 | 18.730 |
| Equity | 275 | 4 | 3.215 | 3.067 | 3.074 | 20.230 | 18.208 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 60 | 48 | 56 | 56 | 19 | 30 | 522 |
| Total debt | 60 | 48 | 56 | 56 | 19 | 30 | 522 |
EBITDA margin
-3862500.0%
This company
15.8%
Market median
-24446303% vs market
20182024
Equity ratio
97.2%
This company
38.2%
Market median
+154% vs market
20182024
Return on equity
8.8%
This company
18.4%
Market median
-52% vs market
20182024
Net profit margin
160024400.0%
This company
8.1%
Market median
+1975609777% vs market
20182024
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20182024
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20182024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2017-11-16 – 2018-12-31
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 25.0% | 100.0% | 2025 | |
| Individual | 20.0% | 0.0% | 2025 | |
| Individual | 20.0% | 0.0% | 2025 | |
| Individual | 20.0% | 0.0% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Receptor Holding ApS (this company)
Embark Holdings ApSBoard members of Receptor Holding ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|